Global Intelligence Hub’s Post

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐓𝐞𝐦𝐩𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 2024-2032: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲:https://lnkd.in/eC7qS_YJ The Patient Temperature Monitoring Market has become integral to modern healthcare, driven by advancements in wearable and non-invasive devices that ensure accurate and continuous patient monitoring. Estimated at USD 7.49 billion in 2023, the market is projected to grow at a CAGR of 6.93%, reaching substantial valuation by 2032. This growth is fueled by the increasing prevalence of chronic diseases, rising demand for at-home healthcare solutions, and technological innovations in smart temperature devices. Our comprehensive market research report provides both quantitative and qualitative insights into the Patient Temperature Monitoring Market, including analysis by product types, applications, regional trends, and leading manufacturers. It also offers insights into competitive strategies and market share estimates for top players, helping stakeholders stay ahead in this evolving industry. Whether you're looking to understand trends in wearable sensors or evaluate opportunities in hospitals, home care, or ambulatory centers, this report equips you with critical information to make informed decisions. Segment-wise growth projections for 2024-2032 highlight consumption value and help businesses target lucrative niches for expansion. 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐜𝐨𝐩𝐞 𝐚𝐧𝐝 𝐃𝐞𝐦𝐚𝐧𝐝 𝐨𝐟 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐓𝐞𝐦𝐩𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠:https://lnkd.in/eC7qS_YJ By Type:Wearable Continuous Monitoring Sensors, Smart Temperature Monitoring Patches, Table-Top Temperature Monitoring Devices, Digital Thermometers, Infrared Thermometers, Invasive and Non-Invasive Monitoring Devices. By Application:Anesthesia, Hypothermia, Fever Management (Pyrexia), Blood Transfusion Monitoring, Others. By Region:North America (US, Canada), Europe (Germany, UK, France, Italy), Asia-Pacific (China, India, Japan), South America, Middle East & Africa (UAE, South Africa). By Key Players:Masimo, Microlife Lab, Koninklijke Kentalis , Terumo Medical Corporation, 3M, Braun Healthcare, Cardinal Health, Hillrom , American Diagnostic CorporationInvitae, Fulgent Genetics, OPKO Health, Inc. ., Thermo Fisher Scientific., Quest Diagnostics, Myriad Genetics Inc., Illumina., Natera., Labcorp , Eurofins Scientific Finland Oy, Sema4.ai, Abbott, Danaher Corporation, MEDGENOME, Genetech Agency, CENTOGENE ., Pathway , BGI Genomics, Ambry Genetics, GeneDx, NxGen MDx, Sonic Healthcare, PerkinElmer #patienttemperaturemonitoring #healthcaremarket #medicaldevices #healthtech #patientcare #temperaturemonitoring #wearabletechnology #globalhealthcare #marketanalysis #marketgrowth

𝗕𝗹𝗼𝗼𝗱 𝗣𝗿𝗲𝘀𝘀𝘂𝗿𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 The Global Blood Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Device Type (Sphygmomanometer/Aneroid BP Monitor, Automated/Digital Blood Pressure Monitor, Transducers, Instruments and Accessories, Blood Pressure Cuffs, Others), By End User (Hospitals, Ambulatory Surgical Centers & Clinics, Homecare), By Distribution Channel (Online, Offline), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dbnbBhBz The Blood Pressure Monitoring Devices Market size was USD 4.5 Billion in 2022. Covid-19's impacts have been unprecedented and staggering on a global scale, with the pandemic leading to positive demand shocks for the blood pressure monitoring devices market across all domains and regions. Between 2023 and 2031, the market is projected to grow at a CAGR of 9.6% from USD 4.1 billion in 2021 to USD 8.6 billion in 2031. The sudden rise in CAGR is attributed to this market growth returning to the pre-pandemic level once the pandemic is over. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬 & 𝐓𝐫𝐞𝐧𝐝𝐬: ◾ Rising Hypertension Cases: Increased prevalence of lifestyle-related disorders globally is driving demand for monitoring devices. ◾ Technological Advancements: The development of wearable BP monitors and smart connected devices for real-time data tracking and integration with healthcare apps. ◾ Shift Towards Homecare: Growing preference for at-home health monitoring solutions, particularly post-pandemic. ◾ Aging Population: A global increase in elderly demographics is fueling demand for easy-to-use blood pressure monitors. 📚 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: 👇 OMRON Healthcare EMEA | Welch Allyn (Hill-Rom) | Philips Healthcare Installation Teams | Nihon Kohden America | A&D Company | Withings | Beurer GmbH | iHealth Labs | Microlife Global | Rossmax Swiss GmbH | American Diagnostic Corporation | Schiller Healthcare India | SunTech | GE HealthCare | Medtronic | Fukuda Denshi USA | EDAN Instruments, Inc. | CONTEC MEDICAL SYSTEMS CO., LTD | Qardio, Inc. | Spacelabs Healthcare | boso | Bosch + Sohn GmbH u. Co. KG | Cardiac Science | Masimo | InBody | AliveCor | CAS Medical Systems | LifeSource | Andon Health Co., Ltd. | BPL Medical Technologies Pvt Ltd | Xiaomi Technology | Omnis Health Life and Wellness Center | Abbott | BIOTRONIK | TensioMed | Pulse Wave Global #bloodpressuremonitoring #healthtech #wearablehealth #remotehealthcare #iotinhealthcare #digitalhealth #hypertensionmanagement #telemedicine #futureofhealthcare #medicaldevices

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐞𝐯𝐢𝐜𝐞𝐬: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬, 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐅𝐮𝐭𝐮𝐫𝐞 𝐒𝐜𝐨𝐩𝐞 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/d4u8XxMu The global diabetes devices market is on a remarkable growth trajectory, driven by innovation and a rising prevalence of diabetes. As millions worldwide live with this chronic condition, the need for effective monitoring and management has never been more critical. 🔍 Market Insights 🔹 Market Growth: As per SNS Insider The Diabetes Devices Market is expected to reach USD 57.15 Billion by 2032, and grow at a CAGR of 7.66%, attributed to the rising adoption of continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, and digital health platforms. 🔹 Innovations Transforming Care: Cutting-edge technologies, like AI-driven data analytics and smartphone integration, are enhancing real-time blood glucose tracking and personalized treatment recommendations. This progress empowers patients and enables healthcare professionals to make data-driven decisions. 🔹 Accessibility & Affordability: Despite these advancements, challenges such as high costs, insurance coverage disparities, and accessibility gaps for patients in low-resource settings remain. Bridging these gaps will be crucial to achieving equitable care. 🚀 Key Trends 🔹 Wearable Technology: CGMs and insulin delivery devices are evolving into smart, wearable tech solutions, offering convenience and more accurate glucose control. 🔹 Telemedicine Integration: Diabetes devices are increasingly incorporating remote patient monitoring, facilitating proactive disease management through telehealth services. 🔹 Data Security & Privacy: As digital platforms gain traction, ensuring the security and privacy of patient data is a pressing issue for manufacturers and regulators. Impact on Patients The ability to monitor glucose levels more easily and accurately not only improves glycemic control but can significantly enhance quality of life, reducing the risk of complications like neuropathy and cardiovascular disease. Major Players Profiled in Study Medtronic Abbott Roche Bayer LifeScan B. Braun Group LifeScan Dexcom Insulet Corporation Ypsomed AG Companion Medical Sanofi Valeritas Holding Inc. Novo Nordisk ARKRAY, Inc. #DiabetesDevices #DiabetesCare #BloodSugarMonitoring #GlucoseMeter #ContinuousGlucoseMonitoring #CGMDevices #DiabetesTechnology #InsulinPump #SmartDiabetes #DiabetesAwareness #DiabetesManagement #WearableHealth #DiabetesInnovation #Type1Diabetes #Type2Diabetes #Dexcom #FreeStyleLibre #MedtronicDiabetes #DiabetesLife #DiabetesSupport

Medical Sensor Market is expected to reach a value of USD 53.8 billion by the end of 2024, and it is further anticipated to reach a market value of USD 273.7 billion by 2033 at a CAGR of 19.8%. #medicalsensors #healthcaretechnology #sensorinnovation #wearablesensors #biometricmonitoring #healthcaredevices #smarthealth #patientmonitoring #medtech #healthsensors #marketshare #marketsize #markettrend #marketdemand #marketresearch #marketanalysis https://lnkd.in/d7VdvxS7

𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐓𝐡𝐞 𝐒𝐞𝐩𝐬𝐢𝐬 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭-IndustryARC™ The Sepsis Diagnostics Market Size is forecast to reach $ 950 Million by 2030, at a CAGR of 7.00% during forecast period 2024-2030. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞@https://lnkd.in/geb8fMbg Sepsis, a critical global health concern, affects millions of people each year. Early detection and timely intervention are pivotal in saving lives, and the Sepsis Diagnostics Market is rising to meet this challenge with groundbreaking innovations. 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 👉 𝐑𝐚𝐩𝐢𝐝 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: New molecular techniques, such as PCR and next-generation sequencing (NGS), are revolutionizing sepsis detection. These methods offer precise and speedy identification of pathogens, enabling earlier and more effective treatment strategies. 👉 𝐏𝐨𝐢𝐧𝐭-𝐨𝐟-𝐂𝐚𝐫𝐞 (𝐏𝐎𝐂) 𝐓𝐞𝐬𝐭𝐢𝐧𝐠: The demand for real-time solutions is driving the adoption of portable POC devices. These tools deliver immediate results, empowering healthcare professionals to make critical decisions at the patient’s bedside. 👉 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬: Biomarkers like procalcitonin (PCT) and C-reactive protein (CRP) are leading the charge in enhancing diagnostic accuracy. Continuous research is uncovering new biomarkers, paving the way for even earlier and more reliable sepsis detection. 👉𝐀𝐈 𝐚𝐧𝐝 𝐃𝐚𝐭𝐚-𝐃𝐫𝐢𝐯𝐞𝐧 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Artificial intelligence is becoming a game-changer in sepsis diagnostics. By analyzing vast amounts of patient data, AI tools can predict sepsis risk and improve diagnostic precision, reducing human error and saving valuable time. 𝐆𝐞𝐭 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨@https://lnkd.in/g3cnzbfV 🌟 𝐅𝐮𝐭𝐮𝐫𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬🌟 The Sepsis Diagnostics Market is poised for robust growth, driven by increasing awareness, advanced healthcare technologies, and rising investment in healthcare infrastructure. Here’s what’s next: 🔹 Personalized Diagnostics: Future solutions will focus on tailoring diagnostics to individual patient profiles, improving outcomes and reducing unnecessary treatments. 🔹 Global Reach: Emerging markets are investing heavily in healthcare, creating immense opportunities for sepsis diagnostic technologies to expand accessibility and affordability. 🔹 Integration of Wearable Tech: Imagine wearables capable of monitoring early sepsis indicators. The integration of wearable devices with diagnostic tools could redefine how we detect and manage sepsis. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 Abbott|Becton Dickenson, |bioMérieux |Bruker|Immunexpress Inc. |Luminex |Response Biomedical Corp.|T2 Biosystems|Thermo Fisher Scientific|Danaher Corporation |Cepheid|Koninklijke Kentalis #SepsisDiagnostics #HealthcareInnovation #AIInHealthcare #EarlyDetection #FutureOfMedicine #MedicalBreakthroughs

🌟 Revolutionizing Hemodialysis: New Wearable Device Monitors Fluid Shifts! 🌟 Accurate fluid tracking is vital for patients with chronic kidney disease undergoing hemodialysis. A groundbreaking study has unveiled a novel wearable sensor that monitors real-time hydration status, offering promising results for improved patient care. 🔍 Innovative Monitoring Technique Involving 31 individuals with end-stage renal disease, the sensor patch placed on the upper back effectively measured extracellular resistance during dialysis sessions. The findings show a strong correlation between resistance changes and fluid removal, highlighting the device's accuracy in tracking hydration levels. 📈 Promising Results - Average increase in resistance: 7.5 Ohm (1st session) & 6.2 Ohm (2nd session) - Average fluid extraction: 1.5 liters & 1.2 liters respectively - Strong correlation (r = 0.82, p < 0.001) between resistance changes and ultrafiltration volume This technology not only enhances monitoring precision but also has the potential to personalize treatment adjustments and improve patient outcomes. 💡 The future of renal care is here! By integrating such wearable technology into routine dialysis practices, healthcare providers can optimize fluid management and reduce complications associated with fluid imbalance. 👉 Click on the link to learn more about this significant advancement in hemodialysis monitoring! #ChronicKidneyDisease #ClinicalResearches #HealthcareInnovation #Hemodialysis #MedTech #PatientCare #Publications #RegulatoryAgencies #WearableTechnology #MarketAccess #MarketAccessToday

𝐑𝐞𝐦𝐨𝐭𝐞 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://lnkd.in/d9ncXDzt 💡 The Remote Cardiac Patient Monitoring Platform Market is experiencing rapid growth, driven by the rising demand for remote healthcare solutions in managing cardiovascular diseases. In 2023, the market was valued at $2.5 billion, and with an anticipated CAGR of 8.6%, it is projected to reach $5.2 billion by 2032. The increasing use of IoT devices, cloud integration, and AI-based analytics in cardiac care has revolutionized the way healthcare professionals monitor and manage heart health remotely. This report dives deep into the evolving technological landscape and the adoption of these platforms across hospitals, clinics, and home healthcare setups, providing insights into key players and regional trends that will shape the market's future. 📊 Our report provides both quantitative and qualitative insights into the Remote Cardiac Patient Monitoring Platform Market, examining manufacturers, regional analysis, types, and applications. The detailed profiles of the leading companies in 2024 offer insights into market share, product innovations, and competitive dynamics, empowering businesses with crucial data to stay ahead. 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐜𝐨𝐩𝐞 𝐚𝐧𝐝 𝐃𝐞𝐦𝐚𝐧𝐝 𝐨𝐟 𝐑𝐞𝐦𝐨𝐭𝐞 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐍𝐨𝐰: https://lnkd.in/d9ncXDzt 𝗕𝘆 𝗧𝘆𝗽𝗲: Wearable Monitoring Devices, Implantable Monitoring Devices, External Monitoring Devices, Mobile Monitoring Platforms, Cloud-Based Solutions 𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals, Home Care, Clinics, Ambulatory Care Centers, Diagnostic Centers 𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa 𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Medtronic, GE HealthCare, Philips, BIOTRONIK, Boston Scientific, Abbott, Hillrom, AliveCor, iRhythm Technologies, Inc., Preventice Solutions, SCHILLER AG, Cardiologs, LifeWatch, BioTelemetry, Inc., InfoBionic.Ai, Corventis, Inc, CAMNTECH LIMITED, CardioComm Solutions Inc., Qardio, Inc., VitalConnect, Biotricity Inc., CardiacSense, LivaNova, ResMed, MediBioSense, iHealth Labs, VectraCor, Telemedcare, Spacelabs Healthcare, G Medical Innovations, eDevice, Welch Allyn #remotehealthcare #cardiaccare #cardiacmonitoring #healthtech #wearabledevices #digitalhealth #patientmonitoring #telehealth #cardiacsolutions #medtech #telemedicine #healthcareinnovation #cardiacdevices #medicalsoftware #ehealth #iotinhealthcare #healthcareplatforms #homecaremonitoring #clinicalcare #remotemonitoring #healthcaresoftware

𝐏𝐮𝐥𝐬𝐞 𝐎𝐱𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐒𝐮𝐫𝐠𝐞 𝐭𝐨 $𝟑.𝟒𝟎 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 ● 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/en5VQqYD Meticulous Research® forecasts that the pulse oximeter market will achieve a value of $3.40 billion by 2031, growing at a CAGR of 5.4% from 2024 to 2031. The market's growth is driven by rising hospitalization rates, increased application in newborn health, and a growing prevalence of chronic respiratory conditions like asthma and COPD. The accessibility of OTC pulse oximeters has further propelled adoption. However, challenges related to data accuracy and regulatory concerns around OTC devices limit broader market growth. Advancements in technology, including wearables and sensor improvements, are unlocking new growth opportunities. Still, mobile-based solutions for blood oxygen monitoring remain a competitive challenge. ● 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic, Philips, Masimo, Nonin Medical, Inc. Medical Solutions , Owlet Baby Care, ICU Medical, GE HealthCare. ● 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 : ⇨𝐄𝐮𝐫𝐨𝐩𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭:  https://lnkd.in/ges9CM5R ⇨𝐏𝐞𝐧 𝐍𝐞𝐞𝐝𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gnCxiJSY ⇨𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gvbfpz3U #PulseOximeter #OximeterMarket #HealthcareDevices #MedicalTechnology #HealthMonitoring #OxygenSaturation #RemotePatientMonitoring #MedicalEquipment #PulseOxInnovation #WearableHealthTech #HomeHealthcare #PulseOximetry #PatientCareSolutions #HealthcareTrends #DigitalHealth #VitalSignsMonitoring #OxygenMonitoring #HealthcareMarketGrowth #MedicalDeviceInnovation #PulseOximeterTrends

Happy to share our latest study Validation and user experience of a dry electrode based Health Patch for heart rate and respiration rate monitoring in Nature Scientific Reports. Here are three key takeaways: ✅ High Accuracy in Heart Rate Monitoring: The Health Patch demonstrated strong agreement with clinical-grade devices, achieving a 98% correlation for heart rate accuracy during both rest and activity. For respiratory rate the agreement was lower. We’ve still got some work to do 😊 ✅ User Comfort and Long-Term Wearability: Designed with self-adhesive dry electrodes, the Health Patch provides greater comfort over prolonged use. Participants reported minimal discomfort, positioning it as a promising solution for continuous, long-term monitoring without the skin irritation typical of gel electrodes. ✅ Potential for Digital Biomarker Development: With robust capabilities in tracking heart rate variability, respiration, and other vital signs, this multimodal technology could be important for developing novel digital biomarkers. Such tools enable early detection of disease and better management of chronic conditions remotely. As healthcare moves towards a more patient-centered approach, wearable technologies like the Health Patch are paving the way for continuous and comfortable monitoring, enhancing patient outcomes and reducing hospital readmissions. 🔗 Link to the paper: https://lnkd.in/eQf9iQd2 Explore more about how wearables are shaping the future of healthcare and how TNO contributes to it: 📔 https://lnkd.in/e422Rwdg 📔 https://lnkd.in/ekqfV3h5 #healthtech #digitalhealth #wearabletechnology #remotemonitoring #digitalbiomarkers #healthinnovation Natallia E. Uzunbajakava, PhD Jonathan Wei, Tim van den Broek, Jan Ubbo van Baardewijk, Robin van Stokkum, Kristel (R.J.M.) Kamstra, Lars Rikken, Kaj Gijsbertse Adam Badar, PhD Annika van Rosmalen